A detailed history of Alta Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Alta Capital Management LLC holds 204,831 shares of NVO stock, worth $22.3 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares
204,831
Previous 109,912 86.36%
Holding current value
$22.3 Million
Previous $15.7 Million 55.46%
% of portfolio
1.48%
Previous 1.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $11.3 Million - $13.8 Million
94,919 Added 86.36%
204,831 $24.4 Million
Q2 2024

Jul 25, 2024

BUY
$122.71 - $146.91 $13.5 Million - $16.1 Million
109,912 New
109,912 $15.7 Million
Q3 2019

Oct 22, 2019

SELL
$47.54 - $53.43 $346,376 - $389,290
-7,286 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$46.79 - $52.47 $489,095 - $548,468
-10,453 Reduced 58.93%
7,286 $371,000
Q1 2019

Apr 23, 2019

SELL
$46.36 - $52.63 $39.1 Million - $44.4 Million
-843,336 Reduced 97.94%
17,739 $927,000
Q4 2018

Jan 09, 2019

SELL
$41.54 - $47.25 $335,310 - $381,402
-8,072 Reduced 0.93%
861,075 $39.7 Million
Q3 2018

Oct 17, 2018

BUY
$46.76 - $51.24 $1.31 Million - $1.43 Million
27,963 Added 3.32%
869,147 $41 Million
Q2 2018

Jul 23, 2018

SELL
$44.29 - $50.42 $50,047 - $56,974
-1,130 Reduced 0.13%
841,184 $38.8 Million
Q1 2018

Apr 06, 2018

SELL
$48.49 - $58.14 $450,569 - $540,236
-9,292 Reduced 1.09%
842,314 $41.5 Million
Q4 2017

Jan 18, 2018

SELL
$47.53 - $53.73 $631,388 - $713,749
-13,284 Reduced 1.54%
851,606 $45.7 Million
Q3 2017

Oct 19, 2017

BUY
$41.15 - $49.22 $35.6 Million - $42.6 Million
864,890
864,890 $41.6 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $245B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Alta Capital Management LLC Portfolio

Follow Alta Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alta Capital Management LLC with notifications on news.